We help pharmaceutical and biotechnology companies make better commercial decisions by speaking directly to the clinicians, payers and patients who shape treatment adoption.
Sentio is a boutique pharmaceutical market research and commercial insights company. We are not a generalist marketing agency, a recruitment-only shop, or an AI consultancy. Clients buy access, judgement, specialist recruitment, research quality, therapeutic knowledge and commercial interpretation.
We combine direct access to healthcare professionals, therapeutic expertise, commercial strategy, high-quality project execution and senior stakeholder management, so findings land as decisions, not slide decks.
We start from the commercial or development question you need to answer, not a generic research checklist.
Specialist recruitment and fieldwork bring you to the clinicians, payers and patients who shape outcomes.
Findings are synthesised into clear implications for positioning, evidence, access and opportunity.
Deliverables are built for decision forums: what to do next, what to prove, and what risk remains.
Leveraging over 30 years of combined experience across industries
CEO & Co-Founder
Investment banking professional with experience at Investec Bank plc and FIS, combining strategic leadership, executive stakeholder management and analytical rigour developed across complex, time-critical financial transactions.
Head of Research
Qualitative healthcare researcher specialising in neurology, oncology and rare diseases. Designs and delivers insight-led research that helps pharmaceutical organisations understand the experiences, behaviours and unmet needs of patients, HCPs and wider healthcare stakeholders.
Head of Sales
Pharmaceutical commercial professional at Eli Lilly and Company, working directly with an extensive network of prescribing consultants across dermatology and rheumatology. Brings frontline insight into HCP engagement, clinical practice and healthcare decision-making.
Head of Medical & Advisory
Qualified medical doctor and former Boston Consulting Group (BCG) consultant with additional life sciences advisory experience at Princeton Biopartners, bringing scientific credibility and strategic perspective to every engagement.
Helping pharmaceutical, biotechnology and healthcare organisations make better strategic, commercial and clinical decisions through rigorous research and meaningful insight.
Every project benefits from the combined perspective of our multidisciplinary team spanning commercial strategy, medical expertise and research excellence to generate insight that supports real-world clinical decision-making.
The responsiveness of a boutique without sacrificing industry-leading quality. Our lean operating model enables faster decision-making, greater flexibility and direct communication, allowing us to adapt quickly to evolving client requirements and compressed project timelines.
Direct access to our leadership team is guaranteed throughout every engagement. Every project is led by senior specialists from initial proposal through to final presentation, ensuring consistency, accountability and exceptional quality at every stage.
Our ethos is to operate as an extension of your team, not another supplier. We integrate into existing teams and operating models. We own the delivery and risks, and ensure high-quality outcomes.
Clinical expertise is embedded throughout the research lifecycle. Medical oversight strengthens study design, discussion guides, analysis and reporting, ensuring every engagement is scientifically robust, clinically relevant and therapeutically accurate.
Research tailored to your most pressing questions. Every engagement is designed around your objectives, selecting the most appropriate qualitative, quantitative or mixed-method approach to generate meaningful, evidence-based insight.
Built around responsible research, data protection and pharmaceutical industry expectations.
We recognise that healthcare market research requires more than strong methodology. It also requires careful governance, transparent participant processes, appropriate data handling and clear procedures for pharmacovigilance and confidentiality.
Our operating framework is being developed with reference to relevant UK healthcare market research, data protection and pharmaceutical industry guidance. Project-specific requirements are agreed with clients before fieldwork begins and adapted according to the markets, audiences and medicines involved.
Research activities are designed with reference to UK GDPR and the Data Protection Act 2018, including appropriate participant information, lawful processing, controlled access, retention and deletion procedures.
Our research approach is informed by the BHBIA Legal and Ethical Guidelines for Healthcare Market Research, including participant transparency, confidentiality, appropriate incentives and separation of research from promotion.
Methodologies and participant practices are developed with reference to the MRS Code of Conduct, including informed participation, accurate reporting, confidentiality and responsible use of research data.
Where research involves medicinal products, project procedures are structured to support the identification and escalation of adverse events, product complaints and special reporting situations in line with applicable client requirements and relevant BHBIA and ABPI guidance.
Participation is voluntary and based on clear information regarding the purpose of the research, recording, confidentiality, data use and withdrawal rights.
Research materials are intended to be handled through controlled systems, restricted access and project-specific retention arrangements, with confidentiality requirements agreed across the delivery team and relevant partners.
References to industry standards and guidance describe the frameworks used to inform our approach. They do not imply certification, accreditation, membership or endorsement by the organisations named. Specific governance, data protection and reporting requirements are agreed for each engagement.
We agree project-specific data protection, pharmacovigilance, confidentiality and participant requirements before research begins.
Discuss your requirementsShare the commercial or development question you are facing. We will come back with a clear view on approach, markets and timing.